819
Views
19
CrossRef citations to date
0
Altmetric
Editorial

Could PKR inhibition modulate human neurodegeneration?

, &
Pages 1455-1457 | Published online: 09 Jan 2014

References

  • Meurs E, Chong K, Galabru J et al. Molecular cloning and characterization of the human doubled-stranded-RNA-activated protein kinase induced by interferon. Cell62(2), 379–390 (1990).
  • Garcia MA, Meurs EF, Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie89(6–7), 799–811 (2007).
  • Li S, Peters GA, Ding K et al. Molecular basis for PKR activation by PACT or dsRNA. Proc. Natl Acad. Sci. USA103(26), 10005–10010 (2006).
  • Peel AL, Rao RV, Cottrell B et al. Double-stranded-RNA dependent protein kinase, PKR, binds preferentially to Huntington’s disease (HD) transcripts and is activated in HD tissue. Hum. Mol. Gen.10(15), 1531–1538 (2001).
  • Chang RCC, Wong AKY, Ng HK, Hugon J. Phosphorylation of eukariotic initiation factor-2α (eIFα) is associated with neuronal degeneration in Alzheimer’s disease. Neuroreport13(18), 2429–2432 (2002).
  • Chang RCC, Suen KC, Ma CH et al. Involvement of double-stranded RNA- dependent protein kinase and phosphorylation of the eukaryotic initiation factor-2α in neuronal degeneration. J. Neurochem.83, 1215–1235 (2002).
  • Suen KC, Yu MS, So KF et al. Upstream signalling pathways leading to the activation of double-stranded- RNA-dependent serine/threonine kinase in β amyloid peptide neurotoxicity. J. Biol. Chem.278(50), 49817–49827 (2003).
  • Peel AL, Bredesen DE. Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice. Neurobiol. Diseases14, 52–62 (2003).
  • Onuki R, Bando Y, Suyama E et al. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer’s disease. EMBO J.23(4), 959–968 (2004).
  • Page G, Rioux-Bilan A, Ingrand S et al. Activated double-stranded-RNA dependent protein kinase and neuronal death in models of Alzheimer’s disease. Neuroscience139(4), 1343–1354 (2006).
  • Paccalin M, Pain-Barc S, Pluchon C et al. Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer’s disease. Dement. Geriatr. Cog. Disord.22(4), 320–326 (2006).
  • Choi Y, Kim HS, Shin KY et al. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer’s disease models. Neuropsychopharmacology32, 2393–2404 (2007).
  • Bando Y, Onuki R, Katayama T et al. Double-stranded RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson’s disease and Huintington’s disease. Neurochem. Int.46, 11–18 (2005).
  • Alirezeai M, Watry DD, Flynn CF et al. Human immunodeficiency virus-1/surface glycoprotein 120 induces apoptosis through RNA-activated protein kinase signalling in neurons. J. Neurosci.27(41), 11047–11055 (2007).
  • Paquet C, Bose A, Polivka M et al. Neuronal phosphorylated RNA dependent protein kinase in Creutzfeldt–Jakob disease. J. Neuropath. Exp. Neurol.68(2), 190–198 (2009).
  • Goggin K, Beaudoin S, Grenier C et al. Prion protein aggresomes are poly(A)+ ribonucleoprotein complexes that induce a PKR-mediated deficient cell stress response. Biochem. Biophs. Acta1783, 479–481 (2008).
  • Lauren J, Gimbel DA, Nygaard HB et al. Cellular prion protein mediated impairment of synaptic plasticity by amyloid-β oligomers. Nature457(7233), 1128–1132 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.